Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC 0.15 0.02
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.075 0.03
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.085 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.072 0.03
mRNA parbendazole CTRPv2 pan-cancer AAC 0.069 0.03
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.04
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.15 0.04
Download CSV